JM Egan

1.5k total citations
15 papers, 1.1k citations indexed

About

JM Egan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, JM Egan has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in JM Egan's work include Pancreatic function and diabetes (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Diabetes Treatment and Management (4 papers). JM Egan is often cited by papers focused on Pancreatic function and diabetes (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Diabetes Treatment and Management (4 papers). JM Egan collaborates with scholars based in United States and Canada. JM Egan's co-authors include Daniel J. Drucker, Susan Bonner‐Weir, Mehboob A. Hussain, Joel F. Habener, Timothy J. Kieffer, Doris A. Stoffers, Marco A. Piñeyro, Jie Zhou, Xiaolin Wang and Chahrzad Montrose‐Rafizadeh and has published in prestigious journals such as Diabetes, Endocrinology and The American Journal of Cardiology.

In The Last Decade

JM Egan

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JM Egan United States 11 794 706 355 237 134 15 1.1k
Irfan Vardarli Germany 15 405 0.5× 773 1.1× 320 0.9× 99 0.4× 67 0.5× 32 1.1k
Maria Gerasimova United States 9 600 0.8× 974 1.4× 528 1.5× 42 0.2× 130 1.0× 12 1.4k
Martin Javorský Slovakia 16 339 0.4× 482 0.7× 367 1.0× 108 0.5× 79 0.6× 36 941
Ivan Tkáč Slovakia 19 382 0.5× 580 0.8× 332 0.9× 60 0.3× 109 0.8× 71 1.0k
Jason Brett United States 13 637 0.8× 1.7k 2.4× 824 2.3× 84 0.4× 51 0.4× 17 1.9k
Leona Plum‐Mörschel Germany 16 599 0.8× 1.1k 1.6× 413 1.2× 126 0.5× 37 0.3× 49 1.4k
Thekkepat C. Sandeep United Kingdom 8 179 0.2× 674 1.0× 95 0.3× 186 0.8× 90 0.7× 9 867
R Takeda Japan 15 572 0.7× 682 1.0× 194 0.5× 54 0.2× 30 0.2× 35 1.2k
Steen H. Ingwersen Denmark 16 233 0.3× 629 0.9× 368 1.0× 58 0.2× 48 0.4× 30 889
Y. Miyazaki United States 15 333 0.4× 833 1.2× 695 2.0× 124 0.5× 30 0.2× 17 1.5k

Countries citing papers authored by JM Egan

Since Specialization
Citations

This map shows the geographic impact of JM Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JM Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JM Egan more than expected).

Fields of papers citing papers by JM Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JM Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JM Egan. The network helps show where JM Egan may publish in the future.

Co-authorship network of co-authors of JM Egan

This figure shows the co-authorship network connecting the top 25 collaborators of JM Egan. A scholar is included among the top collaborators of JM Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JM Egan. JM Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Stoffers, Doris A., Timothy J. Kieffer, Mehboob A. Hussain, et al.. (2000). Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.. Diabetes. 49(5). 741–748. 486 indexed citations
3.
Zhou, Jie, Xiaolin Wang, Marco A. Piñeyro, & JM Egan. (1999). Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells.. Diabetes. 48(12). 2358–2366. 266 indexed citations
4.
Montrose‐Rafizadeh, Chahrzad, et al.. (1997). Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions. Journal of Molecular Endocrinology. 19(3). 241–248. 41 indexed citations
5.
Perfetti, Riccardo, JM Egan, Michael E. Zenilman, & Alan R. Shuldiner. (1996). Differential Expression of reg-I and reg-II Genes During Aging in the Normal Mouse. The Journals of Gerontology Series A. 51A(5). B308–B315. 19 indexed citations
6.
7.
Egan, JM. (1994). Actinomyces pyogenes mastitis with particular emphasis on summer mastitis. 47(4). 180–186. 1 indexed citations
8.
Montrose‐Rafizadeh, Chahrzad, JM Egan, & Jesse Roth. (1994). Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.. Endocrinology. 135(2). 589–594. 37 indexed citations
9.
Abernethy, D R, JM Egan, Tracey Dickinson, & George Carrum. (1988). Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.. Journal of Pharmacology and Experimental Therapeutics. 244(3). 994–999. 18 indexed citations
10.
Dickinson, Tracey, JM Egan, & D R Abernethy. (1988). Effects of Nifedipine on Hepatic Drug Oxidation. Pharmacology. 36(6). 405–410. 4 indexed citations
11.
King, Nicholas M. P., Janice B. Schwartz, John R. Plachetka, Elizabeth L. Todd, & JM Egan. (1987). Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertension. The American Journal of Cardiology. 60(8). 697–702. 30 indexed citations
12.
O’Neill, Padraig Gearoid, JM Egan, D R Abernethy, et al.. (1987). Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium. American Journal of Physiology-Heart and Circulatory Physiology. 252(3). H566–H577. 82 indexed citations
13.
Nelson, Edward, et al.. (1987). The effect of propylene glycol on antipyrine clearance in humans. Clinical Pharmacology & Therapeutics. 41(5). 571–573. 2 indexed citations
14.
Carrum, George, et al.. (1986). Diltiazem treatment impairs hepatic drug oxidation: Studies of antipyrine. Clinical Pharmacology & Therapeutics. 40(2). 140–143. 41 indexed citations
15.
Egan, JM & Nicholas M. P. King. (1986). Lorazepam analysis using liquid chromatography: improved sensitivity for single-dose pharmacokinetic studies. Journal of Chromatography B Biomedical Sciences and Applications. 380(1). 196–201. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irfan Vardarli Breakdown of academic impact, for papers by Maria Gerasimova Breakdown of academic impact, for papers by Martin Javorský Breakdown of academic impact, for papers by Ivan Tkáč Breakdown of academic impact, for papers by Jason Brett Breakdown of academic impact, for papers by Leona Plum‐Mörschel Breakdown of academic impact, for papers by Thekkepat C. Sandeep Breakdown of academic impact, for papers by R Takeda Breakdown of academic impact, for papers by Steen H. Ingwersen Breakdown of academic impact, for papers by Y. Miyazaki
Rankless by CCL
2026